This article has not necessarily been edited by Health24.
TUESDAY, June 29 (HealthDay News) -- The first generic version of Effexor extended release capsules (venlafaxine hydrochloride) to treat major depressive disorder has been approved by the U.S. Food and Drug Administration.
Prescribing information for the generic version of Effexor XR may differ from that of the brand name drug because of various patents held by the brand name drug's maker, Wyeth Pharmaceuticals, the FDA said in a news release. But the same safety warnings will apply.
The generic version will be manufactured by Teva Pharmaceuticals, based in Wales, Penn.
The drug's label includes a warning that antidepressants may raise the risk of suicidal thoughts or tendencies among some children, teens and young adults, the agency said.
To learn more about this drug, visit the U.S. National Library of Medicine.